These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4137436)

  • 1. [Method of obtaining and the characteristics of an antiserum that neutralizes Escherichia coli and Vibrio cholera enterotoxins].
    Likhoded VG; Tabachnik AL; Temper RM
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):36-40. PubMed ID: 4137436
    [No Abstract]   [Full Text] [Related]  

  • 2. The production of diarrhoea in baby rabbits by the oral administration of cell-free preparations of enteropathogenic Escherichia coli and Vibrio cholerae: the effect of antisera.
    Smith HW
    J Med Microbiol; 1972 Aug; 5(3):299-303. PubMed ID: 4560748
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships among heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.
    Gyles CL
    J Infect Dis; 1974 Mar; 129(3):277-83. PubMed ID: 4131518
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae.
    Smith NW; Sack RB
    J Infect Dis; 1973 Feb; 127(2):164-70. PubMed ID: 4570128
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.
    Richards KL; Douglas SD
    Microbiol Rev; 1978 Sep; 42(3):592-613. PubMed ID: 82199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of toxigenicity of Escherichia coli and Vibrio cholerae strains by radioimmunologic method].
    Vertiev IuV; Shaginian IA; Stepanova MV; Ezepchuk IuV
    Mol Gen Mikrobiol Virusol; 1985 Mar; (3):38-40. PubMed ID: 3916223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Noncapsular mutants of Vibrio cholerae serogroup O139: their isolation, identification and use for the preparation of an O139 diagnostic antiserum].
    Chekhovskaia GV; Shchelkanova EIu; Smirnova NI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):34-7. PubMed ID: 10876889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity between heat labile enterotoxins of Vibrio cholerae and Escherichia coli in neutralization tests in rabbit ileum and skin.
    Holmgren J; Söderlind O; Wadström T
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):757-62. PubMed ID: 4592974
    [No Abstract]   [Full Text] [Related]  

  • 10. Modes of action of enterotoxins from Vibrio cholerae and EScherichia coli.
    Field M
    Rev Infect Dis; 1979; 1(6):918-26. PubMed ID: 399384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum.
    Donta ST; Smith DM
    Infect Immun; 1974 Mar; 9(3):500-5. PubMed ID: 4593468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases.
    Spriggs DR; Guerrant RL
    J Infect Dis; 1993 Jan; 167(1):1-6. PubMed ID: 8093361
    [No Abstract]   [Full Text] [Related]  

  • 13. [The isolation and comparative characteristics of sera to the enterotoxin of Vibrio cholerae of the serogroups O139 and O1].
    Mazrukho AB; Lomov IuM; Podosinnikova LS; Lobanov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):86-7. PubMed ID: 10356747
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of a method of passive immune hemolysis on a solid medium for detecting the production of thermolabile enterotoxins by Vibrio cholerae and Escherichia coli strains].
    Shaginian IA; Marakusha BI
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):92-7. PubMed ID: 6353819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholera toxoid boosts serum Escherichia coli antitoxin in humans.
    Nalin DR; al-Mahmud A; Curlin G; Ahmed A; Peterson J
    Infect Immun; 1974 Oct; 10(4):747-9. PubMed ID: 4609909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-neutralization reactions of Escherichia coli and Vibrio cholerae enterotoxins as studied by rabbit skin inoculation test.
    Singh A; Mohan KS; Sethi SK; Vadehra DV
    Acta Microbiol Acad Sci Hung; 1977; 24(1):33-9. PubMed ID: 337760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera-like toxic effect of culture filtrates of Escherichia coli.
    Nalin DR; Bhattacharjee AK; Richardson SH
    J Infect Dis; 1974 Dec; 130(6):595-607. PubMed ID: 4610064
    [No Abstract]   [Full Text] [Related]  

  • 18. The modulating effect of cholera enterotoxin on the immune response.
    Chisari FV; Northrup RS; Chen LC
    J Immunol; 1974 Sep; 113(3):729-39. PubMed ID: 4370486
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholera and cholera-like diarrhoeal diseases: why the differences in severity?
    Abdulkadir SA
    Med Hypotheses; 1991 Mar; 34(3):278-81. PubMed ID: 2062265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
    Saha S; Sanyal SC
    Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.